Patrick J. Christmas Receives Stock Award at Regenxbio Inc (RGNX) — SEC Form 4, Jan 04, 2024

SEC Form 4 · No Market Transaction

Stock Award

Compensation grant — no market purchase or sale.

Reporting Owner

Patrick J. Christmas

TXN 2024-01-02 · FILED 2024-01-04

Equity Position 116K sh 89,037 → 115,759

Equity Change +30.0% shares held after vs before

Filing Lag 2 business days within 2-day SEC deadline

Form 4 · Statement of Changes in Beneficial Ownership

Regenxbio Inc

RGNX CIK 0001590877

Reporting Owner

Name	Relationship
Patrick J. Christmas CIK 0001521123	GC

Patrick J. Christmas at Regenxbio Inc Full insider history

Bought (12 mo) —

Sold (12 mo) —

More from this insider at Regenxbio Inc

Non-Derivative Securities Transactions

Title	Date	Type	Shares	Price	Net Total	Post-Txn	Ownership
Common StockF1	2024-01-02	F - Tax Payment	7,893 D	$17.95	-$141,679	81,144	Direct
Common StockF2	2024-01-02	A - Award/Grant	34,615 A	$0.00	—	115,759	Direct

Derivative Securities Transactions

Title	Strike	Date	Type	Shares	Price	Expiration	Underlying	Ownership
Stock Options (Right to buy)F3	$18.34	2024-01-02	A - Award/Grant	54,945 A	$0.00	2034-01-02	54,945 Common Stock	Direct

Footnotes (3)

F1: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 4, 2021, January 3, 2022 and January 3, 2023. The number of shares withheld was determined on January 2, 2024 based on the closing price of the issuer's common stock on December 29, 2023. Show more
F2: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2025, January 1, 2026, January 1, 2027 and January 1, 2028 while the recipient provides continuous service to the Issuer. Show more
F3: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 2, 2025 while the optionee provides continuous service to the Issuer. Show more

Institutional Holders

Largest by reported value

5%+ Holders · 13D/G 4 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at Regenxbio Inc

GET /v1/forms/4/0001562180-24-000219 API docs